Skip to main content
DosingCalc

BPC-157 and TB-500 Research Guide: Dosing Protocols & Research Applications

8 min read · Updated April 8, 2026

What BPC-157 and TB-500 Are

BPC-157 and TB-500 are two of the most discussed peptides in the research and recovery space. Both are synthetic analogs of fragments found in the body, and both have drawn significant attention for their reported effects on tissue repair, inflammation modulation, and recovery speed.

BPC-157 (Body Protection Compound-157) is a pentadecapeptide derived from a sequence found in human gastric juice. It consists of 15 amino acids and has been studied extensively for its effects on the gastrointestinal tract, tendons, ligaments, and soft tissue healing. TB-500 (Thymosin Beta-4) is a 43-amino acid peptide that mimics the naturally occurring Thymosin Beta-4, a protein found in high concentrations in wound sites and involved in tissue regeneration.

These two peptides get stacked together because they work through complementary mechanisms. BPC-157 tends to act more on the gastrointestinal system and softer tissues, while TB-500 shows stronger activity in muscle, tendon, and cardiac tissue repair. When used together, you report broader-spectrum effects than either peptide alone.

BPC-157 Dosing Protocol

The most common BPC-157 dosing protocol uses 250mcg to 500mcg per day. This can be administered as a single daily injection or split into two doses. Splitting the dose (250mcg in the morning, 250mcg in the evening) is popular because it maintains more stable plasma levels throughout the day.

For most applications, you'll use the lower end of this range. A typical protocol looks like this:

  • Daily dose: 250-500mcg
  • Frequency: Once daily or split twice daily
  • Administration: Subcutaneous injection (usually in the abdomen, thigh, or upper arm)
  • Cycle length: 4-8 weeks

Some protocols use a loading approach with higher initial doses, then drop to maintenance levels. For example, you might start with 500mcg twice daily for the first week, then reduce to 250-500mcg daily for the remaining weeks. However, many users find the standard daily dose works well without a loading phase.

BPC-157 is stable. Unlike some peptides that require precise timing, BPC-157 can be taken at any time of day. Taking it with food doesn't significantly impact absorption, which is unusual for peptides.

You'll find a BPC-157 calculator here that helps you figure out reconstitution volumes and dosing based on the specific vial size and concentration you purchase.

TB-500 Dosing Protocol

TB-500 is typically dosed in milligrams rather than micrograms, which reflects its larger molecular size. The standard protocol uses 2.0-2.5mg per week.

This weekly dose is almost always split into multiple injections. The most common approach is:

  • Weekly dose: 2.0-2.5mg total
  • Frequency: 2-3 times per week (e.g., Monday, Wednesday, Friday)
  • Per-injection dose: 0.7-1.0mg when splitting into three doses, or 1.0-1.25mg when splitting into two
  • Administration: Subcutaneous or intramuscular injection
  • Cycle length: 4-6 weeks for initial use, with optional maintenance

A typical three-injection-per-week protocol would look like this: 0.7mg injected on Monday, Wednesday, and Friday. This gives you 2.1mg per week, which sits comfortably in the standard range.

Some users implement a loading phase with TB-500, similar to peptide protocols that use loading doses. A loading approach might use 4-6mg per week for the first two weeks, then drop to 2.0-2.5mg per week for maintenance. However, the standard 2.0-2.5mg weekly dose is sufficient for most users without loading.

TB-500 is reconstituted with bacteriostatic water like most peptides. Once reconstituted, it should be refrigerated and used within the timeframe specified by the manufacturer (typically 4-8 weeks, depending on storage conditions).

The BPC-157 + TB-500 Stack

Stacking BPC-157 with TB-500 is the most common combination approach in the peptide community. The rationale is simple: these peptides have overlapping but distinct tissue-specific effects, and using them together provides broader support than either alone.

Here's a typical stacked protocol:

Combined Protocol:

  • BPC-157: 250-500mcg daily (one or two doses)
  • TB-500: 2.0-2.5mg per week, split into 2-3 injections
  • Cycle length: 4-6 weeks
  • Administration: Subcutaneous injections for both

One practical note: you can inject both peptides in the same session if you want, but they're usually drawn from separate vials and injected at separate sites. Many users do their BPC-157 injection in the morning and their TB-500 injection on the designated days (e.g., Monday, Wednesday, Friday).

The dosing schedule might look like this in practice:

  • Morning (daily): BPC-157 250-500mcg subcutaneous
  • Monday/Wednesday/Friday: TB-500 0.7-1.0mg subcutaneous (in addition to BPC-157 on those days)

This gives you simultaneous coverage throughout the week. On days when you do both, you can inject them at the same time or several hours apart. There's no strong evidence that timing between the two matters significantly.

A 4-6 week cycle is standard for the stack. After completing a cycle, most users take a break period before running another cycle. The break period is typically equal to or longer than the cycle length (e.g., 4-6 weeks off after 4-6 weeks on).

Practical Administration Details

Reconstituting these peptides properly is essential for getting accurate doses. Both BPC-157 and TB-500 typically come as freeze-dried powders that require reconstitution with bacteriostatic water.

For BPC-157 (usually 5mg vials):

  • Add 1ml of bacteriostatic water to a 5mg vial = 5mg/ml concentration
  • Each 0.1ml on the syringe = 500mcg of peptide
  • Each 0.05ml = 250mcg

For TB-500 (usually 5mg or 10mg vials):

  • Add 1ml of bacteriostatic water to a 5mg vial = 5mg/ml
  • Each 0.2ml = 1mg of peptide
  • Add 2ml of bacteriostatic water to a 10mg vial = 5mg/ml
  • Each 0.2ml = 1mg of peptide

Injection technique matters less for these peptides than for some others. Subcutaneous injection (pinching the skin and injecting into the fat layer) works well for both BPC-157 and TB-500. The abdomen, upper thigh, and upper arm are all suitable sites. Rotating injection sites isn't strictly necessary with these peptides, but it's good practice.

Storage is straightforward: reconstituted peptides should be refrigerated (2-8°C) and kept away from light. Unopened vials can be stored in a cool, dark place. Don't freeze reconstituted peptides.

What Users Report

The most frequently reported effects from the BPC-157 + TB-500 stack relate to recovery and repair. Users commonly report faster healing of tendon injuries, reduced joint pain, improved mobility, and quicker recovery from strenuous activity. These are not FDA-approved uses, and individual results vary significantly.

Those using BPC-157 alone often note improvements in gastrointestinal comfort and function. This makes sense given its origin from gastric juice proteins. Some users report improved skin healing, hair quality, and nail growth, though these effects are more anecdotal.

TB-500 users frequently report improvements in tendon function and joint mobility. The peptide appears to have particular affinity for connective tissue, which aligns with its mechanism of action mimicking Thymosin Beta-4.

When stacked, the effects appear to be additive or synergistic. BPC-157's broader tissue effects complement TB-500's more targeted connective tissue action. This combination is why the stack has become so popular in the peptide community.

Timing and Cycle Considerations

Understanding when to take these peptides and for how long helps you get the most from your protocol.

BPC-157 has a relatively short half-life in the body (measured in hours), which is why daily dosing is standard. Its effects on gastric tissue and the broader systemic distribution mean that daily administration maintains consistent coverage.

TB-500 has a longer effective window, which is why splitting the weekly dose across 2-3 injections works well. The cumulative effect appears to be more important than precise timing.

For cycle length, 4-6 weeks is the sweet spot for most users. Running longer cycles doesn't necessarily provide additional benefit and may lead to diminished returns. After a cycle, taking a break period allows your body to reset. The break period is typically 4-6 weeks, though some users take longer.

If you're new to these peptides, starting with BPC-157 alone for the first cycle is a sensible approach. This lets you assess your individual response before adding TB-500 to the mix.

FAQ

What is the recommended BPC-157 dosing protocol? The most common BPC-157 dosing range is 250mcg to 500mcg per day, administered subcutaneously. Some protocols use twice-daily administration split into 250mcg morning and evening. This can be run for 4-8 weeks before taking a break.

Can BPC-157 and TB-500 be used together? Yes, these peptides are frequently stacked together. BPC-157 is administered at 250-500mcg daily while TB-500 typically uses 2.0-2.5mg per week, split into multiple doses. The combination is believed to provide synergistic effects for tissue repair and recovery.

What is the TB-500 standard dosage? TB-500 is typically dosed at 2.0-2.5mg per week. This can be divided into 2-3 injections throughout the week (e.g., 0.7-1.0mg each dose) or administered as a loading phase followed by lower maintenance doses.

How long should someone run a BPC-157 protocol? BPC-157 protocols typically run 4-8 weeks. Due to its stability and effects on gastric tissue, some protocols extend to 12 weeks. After a break period, cycles can be repeated if needed.

Are BPC-157 and TB-500 safe to use together? These peptides are considered low-risk when used at standard dosages. However, individual responses vary and side effects can occur. It's advisable to start with lower doses to assess tolerance, and consult with a qualified healthcare provider before beginning any peptide protocol.


Disclaimer: This information is for research purposes only. These substances are not FDA-approved for therapeutic use. Consult with a qualified healthcare provider before using any peptides or making changes to your health protocol.

Frequently asked questions

What is the recommended BPC-157 dosing protocol?

The most common BPC-157 dosing range is 250mcg to 500mcg per day, administered subcutaneously. Some protocols use twice-daily administration split into 250mcg morning and evening.

Can BPC-157 and TB-500 be used together?

Yes, these peptides are frequently stacked together. BPC-157 is administered at 250-500mcg daily while TB-500 typically uses 2.0-2.5mg per week, split into multiple doses. The combination is believed to provide synergistic effects for tissue repair and recovery.

What is the TB-500 standard dosage?

TB-500 is typically dosed at 2.0-2.5mg per week. This can be divided into 2-3 injections throughout the week (e.g., 0.7-1.0mg each dose) or administered as a loading phase followed by lower maintenance doses.

How long should someone run a BPC-157 protocol?

BPC-157 protocols typically run 4-8 weeks. Due to its stability and effects on gastric tissue, some protocols extend to 12 weeks. After a break period, cycles can be repeated if needed.

Are BPC-157 and TB-500 safe to use together?

These peptides are considered low-risk when used at standard dosages. However, individual responses vary and side effects can occur. It's advisable to start with lower doses to assess tolerance, and consult with a qualified healthcare provider before beginning any peptide protocol.